Exploratory Study on the Potential Cross-System Effects of BCI-FES Hand Therapy on Dysphagia and Aphasia in Chronic Stroke Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVASCage GmbH

About this trial

The goal of this neurorehabilitation explorative study is to investigate how a closed-loop Brain-Computer Interface Functional Electrical Stimulation (BCI-FES) therapy, used within the intended purpose for hand rehabilitation, may impact swallowing difficulties (dysphagia) and language disorders (aphasia) in post-stroke patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: Participants must be aged 18 years or older.

Post-Stroke Phase: Participants must be within the chronic post-stroke phase (time since ischemic or haemorrhagic stroke greater than 3 months).

Motor Impairment: Participants must exhibit disabling left or right residual arm paresis ("left/right arm motor drift" part of the NIHSS score ≥1).

Aphasia (AAT-Skala zum Kommunikationsverhalten score ≤3), and/or

Disqualifiers

Cognitive Impairments: Cognitive impairments that, in the investigator's judgment, could limit understanding of task instructions.

Stroke Location: Participants with a brainstem and/or cerebellar stroke.

Previous Stroke: Participants with a previous disabling stroke.

Hemi-Neglect: Pronounced hemi-neglect at the last documented therapy visit that limits compliance with treatment intervention (investigator's judgment).

Trial design

Design model

Single group

Treatments tested in this trial

  • closed-loop BCI-FES device

    Device

    Closed-loop neurorehabilitation system that combines EEG-based brain-computer interface technology with functional electrical stimulation (FES) to facilitate neural and motor recovery.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: All participantsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Gugging Swallowing Screen (GUSS)

The GUSS is a standardised assessment tool used to evaluate swallowing ability and the risk of aspiration in patients with dysphagia. 4-step clinical assessment; total score ranges from 0 to 20 points. It includes an initial screening followed by assessments of different consistencies of food and drink to determine swallowing safety.

Time frame
Baseline, treatment session 16, week 17, week 21 and week 47
2

Change in Bielefeld Aphasia Screening Reha (BIAS-R)

The BIAS-R is a validated, and standardised assessment tool specifically designed to assess language impairments in aphasic patients in the post-acute stage. It evaluates different aspects of language function such as comprehension, expression, and overall communication ability for different linguistic domains. It is a score-based aphasia screening tool; total score indicates severity of language impairment.

Time frame
Baseline, treatment session 16, week 17, week 21 and week 47

Secondary outcomes

1

Change in Munich Swallowing Score (MUCCS)

The MUCCS assesses swallowing function by rating specific criteria related to oral and pharyngeal swallowing phases on two subscales related to saliva swallow (MUCCS-S and oral intake (MUCCS-N). It is a 16-point Likert scale clinical rating.

Time frame
Baseline, week 17, week 21 and week 47
2

Change in M.D. Anderson Dysphagia Inventory (M.D.ADI)

The M.D.ADI evaluates the impact of dysphagia on a patient's quality of life. 20-item, 5-point Likert scale per item. Provides subscale scores (emotional, functional, physical) and a total composite score. Composite Score ranges from 20 (extremely low functioning) to 100 (high functioning).

Time frame
Baseline, week 17, week 21 and week 47
3

Change in Communication Outcome after Stroke (COAST)

The COAST measures the impact of stroke on communication abilities and social participation, focusing on how well individuals are able to interact in everyday situations. The primary caregiver of the study participant will complete this outcome assessment. 2 domains, each item rated on a 5-point Likert scale.

Time frame
Baseline, week 17, week 21 and week 47
4

Change in Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

The FMA-UE is a stroke-specific assessment used to evaluate motor recovery in the upper extremity, focusing on range of motion, coordination, and reflexes. Ordinal 3-point scale per item (0-2); maximum score: 66.

Time frame
Baseline, week 17, week 21 and week 47

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

VASCage GmbH

Lead sponsor

g.tec medical engineering GmbH

Collaborator

Medical University Innsbruck

Collaborator